CN107056898A - 3 type of carp herpesviral, 1301 plants of ORF136 DNA recombinant expressions albumen, antibody and its application - Google Patents

3 type of carp herpesviral, 1301 plants of ORF136 DNA recombinant expressions albumen, antibody and its application Download PDF

Info

Publication number
CN107056898A
CN107056898A CN201710076686.6A CN201710076686A CN107056898A CN 107056898 A CN107056898 A CN 107056898A CN 201710076686 A CN201710076686 A CN 201710076686A CN 107056898 A CN107056898 A CN 107056898A
Authority
CN
China
Prior art keywords
orf136
polyclonal antibody
seq
recombinant expression
recombinant
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201710076686.6A
Other languages
Chinese (zh)
Inventor
王庆
郑树城
李莹莹
曾伟伟
王英英
刘春�
任燕
石存斌
黄琦雯
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pearl River Fisheries Research Institute CAFS
Original Assignee
Pearl River Fisheries Research Institute CAFS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pearl River Fisheries Research Institute CAFS filed Critical Pearl River Fisheries Research Institute CAFS
Priority to CN201710076686.6A priority Critical patent/CN107056898A/en
Publication of CN107056898A publication Critical patent/CN107056898A/en
Pending legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/06Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies from serum
    • C07K16/065Purification, fragmentation
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/08Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/081Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from DNA viruses
    • C07K16/085Herpetoviridae, e.g. pseudorabies virus, Epstein-Barr virus
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/70Vectors or expression systems specially adapted for E. coli
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011Details
    • C12N2710/16011Herpesviridae
    • C12N2710/16022New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2800/00Nucleic acids vectors
    • C12N2800/10Plasmid DNA
    • C12N2800/101Plasmid DNA for bacteria

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Virology (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Wood Science & Technology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Plant Pathology (AREA)
  • Peptides Or Proteins (AREA)

Abstract

The invention discloses a kind of 3 type of carp herpesviral, 1301 plants of ORF136 DNA recombinant expressions albumen, polyclonal antibody and its application.3 type of carp herpesviral, 1301 plants of ORF136 DNA recombinant expression albumen that the present invention is provided, its full length amino acid sequence such as SEQ ID NO:Shown in 2, the full length nucleotide sequence such as SEQ ID NO of the albumen are encoded:Shown in 1.The present invention chooses ORF136 partial gene sequences and builds pET32a ORF136 recombinant prokaryotic expression vectors, recombinant expression protein is obtained after IPTG induced expressions, polyclonal antibody is obtained through immune rabbit, gained polyclonal antibody is subjected to western blot analyses with the viruses of CyHV 3 of purifying and infection CyHV 3 KS cells, and the detection application of antibody is further verified using indirect immunofluorescence experiment.The be prepared as research of ORF136 protein functions and the foundation of the serological diagnostic methods of CyHV 3 of ORF136 DNA recombinant expression protein polyclone antibodies provide important materials.

Description

3 type of carp herpesviral, 1301 plants of ORF136 DNA recombinant expressions albumen, antibody and its Using
Technical field
The invention belongs to biological gene engineering field, and in particular to by 3 type of carp herpesviral, 1301 plants of ORF136 gene weights Group expressing protein, the polyclonal antibody prepared by ORF136 recombinant expression proteins and its application, further to polyclonal antibody Preparation method.
Background technology
The type of carp herpesviral 3 (Cyprinid Herpesvirus 3, CyHV-3), also known as Koi herpesvirus (Koi Herpesvirus, KHV), it is to cause carp, fancy carp and its mutation highly infectious Koi herpesvirus disease (Koi Herpesvirus disease, KHVD) cause of disease.The disease is since 1997 since Europe is found, multiple countries and regions are all Report as carp caused by the disease or the fancy carp fulminant phenomena of mortality, brought to carp and fancy carp aquaculture industry serious Economic loss.CyHV-3 belongs to herpesviral mesh, different herpetoviridae, carp Herpesvirus, is the double-stranded DNA disease with cyst membrane Poison, a diameter of 167~200nm of virion, full-length genome 295kbp, two ends are 22kbp direct repetitive sequence, altogether coding 164 ORFs (Open reading frame, ORF), including 8 repetition ORF, are the maximum blebs of known group Virus.
At present, 46 kinds of virus structural proteins have been identified with the method for mass-spectrometry.Wherein, Michel etc. uses liquid phase string It is unknown that connection chromatographic technique identifies 13 kinds of envelope proteins, 3 kinds of nucleocapsid proteins, 2 seed coat layer albumen and 22 kinds in KHV-FL plants Albumen totally 40 kinds of structural proteins.Then, Yi etc. is to Asian type KHV-GZ10 and Europe class KHV-GZ11 by carrying out Mass Spectrometric Identification, The structural proteins of identification are increased to 46 kinds.Certain recognize although identifying there are CyHV-3 virus proteins by proteomic image Know, but most of albumen is accurately positioned with functional study still in blank, and only a small number of albumen have carried out more deep identification, Wherein, ORF81 encoding proteins are one of more structural proteins of research.In addition, Fuchs etc. also to part envelope protein ORF25, ORF65, ORF99, ORF136, ORF149 and major capsid protein ORF92 have carried out Preliminary Identification.
There is nucleotide sequence difference in the ORF136 that the present invention is selected, it is completely opened in Asian type and Europe class separation strains It is respectively 474bp and 462bp to put reading frame length, the gene can as CyHV-3 molecule partings effective tool.Although albumen Mass spectral analysis shows that ORF136 encoding proteins are structural proteins, but has no specific checking, and its deep functional localization is also unclear Chu, more correlative studys still need to be carried out.
Although existing many CyHV-3 checkout and diagnosis method at present, main in it is also based on point actual The detection technique of son, serodiagnosis is not widely used.For the host of latent infection, it is based on The detection of molecule can not be judged with the presence or absence of virus in host, and serodiagnosis can overcome the disadvantages that this defect.It is based on The foundation of immunologic antigen detection method, it is desirable to have energy specific recognition CyHV-3 antibody.
The content of the invention
In view of the shortcomings of the prior art, the present invention provides a kind of 3 type of lithium herpesviral, 1301 plants of ORF136 genetic recombination tables Up to albumen and its polyclonal antibody of preparation, it is further provided the polyclonal antibody is used to detect answering for ORF136 gene viruses With, and polyclonal antibody preparation method.
To solve the above problems, on the one hand, the invention reside in provide a kind of 1301 plants of ORF136 genes of 3 type of carp herpesviral Recombinant expression protein, its full length amino acid sequence such as SEQ ID NO:Shown in 2.
On the other hand, the invention reside in provide a kind of coding carp herpesviral 3 type, 1301 plants of ORF136 DNA recombinant expressions The nucleotides of albumen, its full length nucleotide base sequence such as SEQ ID NO:Shown in 1.
On the one hand, the present invention provides a kind of polyclonal antibody, and it is with amino acid sequence such as SEQ ID NO:Weight shown in 5 Group expressing protein is obtained by antigen is prepared in immune animal.
Further, it is of the present invention such as SEQ ID NO:Amino acid sequence shown in 5 is SEQ ID NO:Ammonia shown in 2 A part for base acid sequence;Its specific preparation process is that carp herpesviral 3 type, 1301 plants of ORF136 genes are entered into performing PCR amplification Afterwards, recombinant cloning vector pMD18-T-ORF136 is obtained;By recombinant cloning vector pMD18-T-ORF136, prokaryotic expression carrier PET-32a (+) is attached after carrying out double digestion respectively, builds recombinant prokaryotic expression vector pET-32a-ORF136;By pET- 32a-ORF136 is converted to Escherichia coli Rosetta and obtained after IPTG induced expressions such as SEQ ID NO:Restructuring table shown in 5 Up to albumen.
Further, Anti-TNF-α production procedure of the present invention is as follows:Will be such as SEQ ID NO:Restructuring shown in 5 Expressing protein carries out subcutaneous multi-point injection to rabbit and is immunized, and is taken a blood sample after being immunized;After blood is stood, serum is collected in centrifugation, Purified with the mode antagonistic Serum of affinity purification, obtain polyclonal antibody.
On the other hand, the invention reside in provide a kind of polyclonal antibody of the present invention to be used to prepare detection carp blister sore The application of the immune instrument of malicious 3 types.Immune instrument of the present invention includes but is not limited to, reagent, kit, chip or examination Paper.
Further, polyclonal antibody of the present invention draws in detection, prevention or the type infection for the treatment of carp herpesviral 3 Application in the relevant disease risen.
On the other hand, the invention reside in a kind of kit for detecting the type of carp herpesviral 3 is provided, containing of the present invention The antibody of carp herpesviral 3 type, 1301 plants of ORF136 DNA recombinant expression albumen.
On the other hand, the present invention provides a kind of method for preparing polyclonal antibody of the present invention, specific preparation process It is as follows:
1) expand:Using 3 type of carp herpesviral, 1301 plants of DNA as template, design specific primer is to ORF136 gene codes Performing PCR amplification is entered in the 91st~471 nucleotide region of albumen, obtains recombinant cloning vector pMD18-T-ORF136;
2) build:Recombinant cloning vector pMD18-T-ORF136, prokaryotic expression carrier pET-32a (+) are carried out respectively double Connected after digestion, build recombinant prokaryotic expression vector pET-32a-ORF136;
3) express:PET-32a-ORF136 is converted to Escherichia coli Rosetta and obtained after IPTG induced expressions such as SEQ ID NO:Recombinant expression protein shown in 5;
4) prepare:Will be such as SEQ ID NO:Recombinant expression protein shown in 5 is taken a blood sample after being immunized in immune animal;It is right Blood obtains polyclonal antibody after being handled.
Further, a kind of method for preparing polyclonal antibody of the present invention of the present invention, the step 2) The system of middle digestion is:10 × buffer 2ul, EcoR I and Xho I each 1ul, plasmid 1ug, mend ddH2O water is to 20ul;37℃ Water-bath digestion 2h.
Further, a kind of method for preparing polyclonal antibody of the present invention of the present invention, the step 2) The system of middle connection is:T4Ligase 1.5uL, 10 × T4Ligase buffer 1.5uL, pET-32a (+) 3uL, after digestion Fragment 9uL;16 DEG C of connections are stayed overnight.
Further, a kind of method for preparing polyclonal antibody of the present invention of the present invention, the step 3) Middle pET32a-ORF136 is converted into Escherichia coli Rosetta, screening positive clone, is inoculated in the LB culture mediums containing ammonia benzyl In, culture to OD600 is 0.4, adds IPTG and carries out after induced expression, thalline is collected by centrifugation, thalline is cleaned, crushed, Collected after centrifugation inclusion body protein, inclusion body protein obtains recombinant expression protein after purification.
Further, a kind of method for preparing polyclonal antibody of the present invention of the present invention, the step 3) Middle bacterial cell disruption is using ultrasonic disruption on ice.
Further, a kind of method for preparing polyclonal antibody of the present invention of the present invention, the step 4) Middle recombinant expression protein carries out subcutaneous multi-point injection in immune animal and is immunized, and is taken a blood sample after being immunized;After blood is stood, from The heart, collects serum, is purified with the mode antagonistic Serum of affinity purification, obtain polyclonal antibody.
Further, specific primer of the present invention is
F:CCGGAATTCGGCACAACAACCATGAACTCTACC(SEQ ID NO:3) (restriction enzyme sites of I containing EcoR, are shown in Underscore part)
R:CCGCTCGAGTTAGATTTTTCTAAAGTGCACGACGTC(SEQ ID NO:4) (restriction enzyme sites of I containing Xho, See below dashed part).
The present invention passes through bioinformatics software, the amino acids of screening KHV ORF136 gene coded proteins the 31st~157 Region is more complete potential B cell antigen epi-position, builds pET-32a-ORF136 recombinant prokaryotic expression vectors;Lured by IPTG Purification of recombinant proteins after expression is led, polyclonal antibody, and CyHV-3 viruses and infection CyHV- with purifying are obtained through immune rabbit 3 KS cells carry out immunoblotting assay (Western blot), and further verify antibody using indirect immunofluorescence experiment Detection application.The ORF136 protein functions that are prepared as of ORF136 DNA recombinant expression protein polyclone antibodies are studied and CyHV-3 The foundation of serological diagnostic method provides important materials.
The preparation method of antibody of the present invention has the higher rate of recovery and preferably keeps the bioactivity of albumen, is adapted to big Scale purification and preparation.The purity of polyclonal antibody is high in the present invention, it is easy to industrialization.
Compared with prior art, the present invention has the advantages that:The present invention provides a kind of type 1301 of carp herpesviral 3 Strain ORF136 DNA recombinant expression albumen, and the albumen is produced into polyclonal antibody.The recombinant protein can be used for carp herpesviral 3 The detection application of type.The present invention provides a kind of energy specific recognition CyHV-3 polyclonal antibody, and provides the ORF136 of preparation The method of DNA recombinant expression protein polyclone antibody, the virus of the Anti-TNF-α physical efficiency specific recognition purifying and infection CyHV-3 cell, has certain application value in the foundation of follow-up CyHV-3 serological diagnostic methods, available for it is clinical, Test in laboratory and epidemiological study.The preparation method that the present invention is provided is simple, easy to operate.
Brief description of the drawings
Fig. 1 is CyHV-3ORF136 genes (the 91st~471 nucleotides) pcr amplification product electrophoretogram;M is DL in Fig. 1 marker 2000;1 is the pcr amplification product using KHV DNA as template;
Fig. 2 is recombinant plasmid pET32a-ORF136 double digestion qualification results;M is DL marker 10000 in Fig. 2;1 is Recombinant plasmid pET32a-ORF136 double digestion products;2 be empty carrier pET32a (+) double digestion product;
Fig. 3 is that SDS-PAGE analyzes recombinant plasmid pET32a-ORF136 expression products;M is low molecule quality protein in Fig. 3 Matter marker;1 is pET32a-ORF136 induced expression supernatants;2~4 be 2 times of pET32a-ORF136 induced expressions inclusion body, 5 Diluted again with 10 times;
Fig. 4 is that western blot analyze ORF136 encoding proteins antiserum characteristics;M Low molecular weight proteins in Fig. 4 marker;1 1301 plants of the CyHV-3 to purify;2 be infection CyHV-3 KS cells;3 be to be uninfected by CyHV-3 KS cells Clearly;The 4 KS cells to be uninfected by;
Fig. 5 is the cell that virus infection is detected using polyclonal antibody;A is thin for 1301 plants of CyHV-3 of inoculation KS in Fig. 5 Born of the same parents;B is the normal KS cell controls of non-virus inoculation.
Embodiment
With reference to embodiment, the present invention is further illustrated, but is not limited thereto.
Molecular biology experiment technology employed in following examples include PCR amplifications, plasmid extraction, plasmid convert, DNA fragmentation connection, digestion, gel electrophoresis etc., unless otherwise specified, generally conventionally operate, for details, reference can be made to《Molecule Cloning experimentation guide》(third edition) (Sambrook J, Russell DW, Janssen K, Argentine J. Huang Peitangs etc. are translated, 2002, Beijing:Science Press), or according to the condition proposed by manufacturer.
Embodiment 1
Step 1: the amplification of 1301 plants of ORF136 genes of KHV
According to CyHV-3ORF136 gene orders in GenBank, with bioinformatics software ABCpred (http:// www.imtech.res.in/raghava/abcpred/)、BepiPred 1.0(http://www.cbs.dtu.dk/ Services/BepiPred/) and DNAstar submodules Protean prediction the potential B cell antigen epi-position of ORF136 genes.
With the designs of Primer Premier 5.0 specific primer, (specific primer is:
F:CCGGAATTCGGCACAACAACCATGAACTCTACC(SEQ ID NO:3) (restriction enzyme sites of I containing EcoR, are shown in Underscore part),
R:CCGCTCGAGTTAGATTTTTCTAAAGTGCACGACGTC(SEQ ID NO:4) (restriction enzyme sites of I containing Xho, See below dashed part),
And synthesized by Sheng Gong biotech firms.
Viral genome, which is extracted, presses blood/cell/tissue DNA extraction kit (Tiangeng biochemical technology Co., Ltd, north Capital) in specification carry out.
PCR reaction systems:12.5ul rTaq Mix, each 1ul of primer (10umol/L) and 1ul DNA profilings, mend aqua sterilisa To 25ul.
Response procedures are as follows:94 DEG C, 5min;94 DEG C, 30s, 55 DEG C, 30s, 72 DEG C, 45s, 30 circulations;72 DEG C, 7min.
Using F/R as primer, for the potential B cell antigen epi-position region of ORF136 genes (i.e. ORF136 gene coded proteins 91st~471 nucleotide region, i.e. the 31st~157 amino acids region), with 3 type of carp herpesviral, 1301 plants are entered for template Performing PCR is expanded, and 1.5% agarose electrophoretic analysis display obtains a band being consistent with expected size, and clip size is 381bp (specific as shown in Figure 1).
Step 2: recombinant prokaryotic expression vector pET32a-ORF136 structure
Recombinant cloning vector pMD18-T-ORF136, the prokaryotic expression carrier pET-32a (+) that step one is expanded are entered respectively Row double digestion (enzyme is EcoR I and Xho I enzymes), and the prokaryotic expression after recombinant cloning vector Insert Fragment and double digestion is carried Body is attached, and obtains recombinant prokaryotic expression vector.Experiment condition is as follows:
Digestion system is:10 × buffer 2ul, EcoR I and Xho I each 1ul, plasmid 1ug, mend dd H2O water is extremely 20ul.37 DEG C of water-bath digestion 2h.After digestion, electroresis appraisal digestion effect, and to vector insert 0RF136 in recombinant clone Rubber tapping recovery is carried out with the prokaryotic expression carrier pET-32a (+) after double digestion.
Linked system:T4Ligase 1.5uL, 10 × T4Ligase buffer 1.5uL, pET-32a (+) 3uL, digestion Fragment 9uL afterwards.16 DEG C of connections, overnight.
Connection product is converted to DH5 α competent cells, screening positive clone carries out bacterium solution PCR.
The recombinant prokaryotic expression vector pET32a-ORF136 of structure is subjected to double digestion identification, obtained and expected size phase Two band of symbol, show that recombinant prokaryotic expression vector is successfully constructed (specific as shown in Figure 2).
Step 3: protein expression
Step 2 is identified that correct recombinant prokaryotic expression vector pET32a-ORF136 is converted to Escherichia coli Rosetta (DE3) in, screening positive clone is inoculated in the LB culture mediums containing ammonia benzyl, at 37 DEG C shaking table culture to OD600 be 0.4, The IPTG for adding final concentration of 0.8mM carries out 10000rpm/min centrifugations 5min collection thalline after induced expression, 4h, carries out a small amount of Expression identification.
By the thalline of collection with after PBS 2 times, it is resuspended, in ultrasonic disruption on ice, 10000rpm/min centrifugations 5min, collects supernatant inclusion body precipitation, with sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) respectively Identified.
SDS-PAGE is analyzed, and as a result shows the protein band for obtaining and being consistent with purpose size, size is about 35kDa (carriers The amino acids of about 20kDa, ORF136 the 31st~157 prediction molecular weight of albumen is about 14kDa), and destination protein is mainly distributed In inclusion body (Fig. 3).
Inclusion body protein is purified with reference to the method for Ni- gel purification kits, the recombination expression egg purified In vain, its amino acid sequence such as SEQ ID NO:Shown in 5.
Step 4: polyclonal antibody preparation and purification
The recombinant expression protein that step 3 is purified is immune to the subcutaneous multi-point injection of rabbit progress, and (first immunisation uses Freund Freund's complete adjuvant, latter three times immune to use incomplete Freund's adjuvant, and adjuvant and recombinant expression protein volume ratio are 1:1), it is immunized 66 days Afterwards, arteria carotis blood sampling is carried out.Blood is stood after 1h in 37 DEG C, 3000rpm/min centrifugation 10min collect serum, with affine pure The mode antagonistic Serum of change is purified, and obtains polyclonal antibody, in preservation at -20 DEG C.
Embodiment 2
SDS-PAGE and immunoblotting assay (Western blot)
Polyacrylamide gel is made up of 12% separation gel and 4% concentration glue, by 1301 plants of diseases of CyHV-3 of purifying Poison, RIPA lysates cracking postoperative infection CyHV-3 KS cells and be uninfected by CyHV-3 KS cells respectively with 5 × albumen loading Buffer solution heats point sample after 5min, cooling in boiling water and carries out electrophoretic analysis (200V, 35min) after mixing in proportion.By SDS- Gel after PAGE separation is transferred to nitrocellulose filter, 5% closing of skimmed milk power room temperature 1h, Ran Houyong with wet turn of method Sealer 1:The polyclonal antibody that the step 4 of embodiment 1 of 1000 dilutions is obtained is incubated 1h at room temperature, then with 0.05% PBST is cleaned 3 times, each 10min;Finally use sealer 1:The HRP mark goat anti-rabbit igg incubation at room temperature 1h of 10000 dilutions, are used 0.05% PBST carries out DAB colour developings after cleaning 3 times.
Western blot analysis results show occur a specific band (as shown in Figure 4) between 15~25kDa, ORF136 encoding proteins predicted molecular weights are about 17kDa, in the same size with expection, illustrate Anti-TNF-α physical efficiency prepared by the present invention Specific recognition CyHV-3.
Embodiment 3
Indirect immunofluorescence assay detects infection cell
Fancy carp kiss teloblast (KS cells) is passaged in 96 porocyte culture plates, treats that cell length to individual layer is paved with 80% left Behind the right side, the strain virus of CyHV-3 1301 is infected;Infect after virus 5 d, the culture medium in Tissue Culture Plate is exhausted, 0.01mol/ is used L PBS is washed 3 times, is added 80% acetone soln incubation at room temperature 30min, is sucked acetone, drying at room temperature 1h;Add 100 μ l per hole 1:The rabbit-anti ORF136 protein polyclone antibodies of 1000 dilutions, 37 DEG C are incubated 1h, and PBST is washed 3 times, adds 1:The sheep of 50 dilutions Fluorescence secondary antibody 100 the μ l, 37 DEG C of incubation 1h of anti-rabbit IgG-FITC marks;PBST is washed 3 times, is eventually adding nucleus dyestuff iodate Third pyridine (PI) acts on and observes result under 5min, fluorescence inverted microscope (Nikon, Eclipse Ti-S).Negative control is not feel Catch an illness poison normal KS cells.
The result of indirect immunofluorescence experiment shows that the Anti-TNF-α physical efficiency of preparation makes the strains of infection CyHV-3 1301 KS cells can produce specific fluorescence (see Fig. 5 A), and not observe fluorescence signal in the normal KS cells of uninfecting virus (Fig. 5 B).
The preferred embodiments of the present invention are the foregoing is only, are not intended to limit the invention, for the skill of this area For art personnel, the present invention can have various modifications and variations.Within the spirit and principles of the invention, that is made any repaiies Change, equivalent substitution, improvement etc., should be included in the scope of the protection.
SEQUENCE LISTING
<110>China's Pearl River Fishery Research Institute of Aquatic Science Research Institute
<120>3 type of carp herpesviral, 1301 plants of ORF136 DNA recombinant expressions albumen, antibody and its application
<130> 2017
<160> 5
<170> PatentIn version 3.5
<210> 1
<211> 474
<212> DNA
<213>It is unknown
<400> 1
atgaaggcct ctaaactgct gctggttaca tgggtggctt tcgcggccgg ccagaacgcc 60
accaccctgg ctccgctcgc cgccactaac ggcacaacaa ccatgaactc tacctggtcc 120
tctaccgctt cagtcatgaa ctctactacc tggtcctcta ctatgaactc tacctggtcc 180
accaccaccg cggcgagcgg cgactcttgg tggcgcccag aagaggtgct gtctaggtgt 240
agggaccagg ccggactgaa ctggctgggg tgcgctcagg gtatggtggt ggtgatggtc 300
atcttcgcta tcatctttgc catcatcgtg atcgtcgtgg tgtgggtgct gatgcacgtc 360
gtgatcgccc gtcgcgaccc agccggcgcg gcagggccag gagccatgtc tgcatcctac 420
aacaggggct acgtcgagga tgaagacgac gtcgtgcact ttagaaaaat ctaa 474
<210> 2
<211> 157
<212> PRT
<213>It is unknown
<400> 2
Met Lys Ala Ser Lys Leu Leu Leu Val Thr Trp Val Ala Phe Ala Ala
1 5 10 15
Gly Gln Asn Ala Thr Thr Leu Ala Pro Leu Ala Ala Thr Asn Gly Thr
20 25 30
Thr Thr Met Asn Ser Thr Trp Ser Ser Thr Ala Ser Val Met Asn Ser
35 40 45
Thr Thr Trp Ser Ser Thr Met Asn Ser Thr Trp Ser Thr Thr Thr Ala
50 55 60
Ala Ser Gly Asp Ser Trp Trp Arg Pro Glu Glu Val Leu Ser Arg Cys
65 70 75 80
Arg Asp Gln Ala Gly Leu Asn Trp Leu Gly Cys Ala Gln Gly Met Val
85 90 95
Val Val Met Val Ile Phe Ala Ile Ile Phe Ala Ile Ile Val Ile Val
100 105 110
Val Val Trp Val Leu Met His Val Val Ile Ala Arg Arg Asp Pro Ala
115 120 125
Gly Ala Ala Gly Pro Gly Ala Met Ser Ala Ser Tyr Asn Arg Gly Tyr
130 135 140
Val Glu Asp Glu Asp Asp Val Val His Phe Arg Lys Ile
145 150 155
<210> 3
<211> 33
<212> DNA
<213>It is unknown
<400> 3
ccggaattcg gcacaacaac catgaactct acc 33
<210> 4
<211> 36
<212> DNA
<213>It is unknown
<400> 4
ccgctcgagt tagatttttc taaagtgcac gacgtc 36
<210> 5
<211> 127
<212> PRT
<213>It is unknown
<400> 5
Gly Thr Thr Thr Met Asn Ser Thr Trp Ser Ser Thr Ala Ser Val Met
1 5 10 15
Asn Ser Thr Thr Trp Ser Ser Thr Met Asn Ser Thr Trp Ser Thr Thr
20 25 30
Thr Ala Ala Ser Gly Asp Ser Trp Trp Arg Pro Glu Glu Val Leu Ser
35 40 45
Arg Cys Arg Asp Gln Ala Gly Leu Asn Trp Leu Gly Cys Ala Gln Gly
50 55 60
Met Val Val Val Met Val Ile Phe Ala Ile Ile Phe Ala Ile Ile Val
65 70 75 80
Ile Val Val Val Trp Val Leu Met His Val Val Ile Ala Arg Arg Asp
85 90 95
Pro Ala Gly Ala Ala Gly Pro Gly Ala Met Ser Ala Ser Tyr Asn Arg
100 105 110
Gly Tyr Val Glu Asp Glu Asp Asp Val Val His Phe Arg Lys Ile
115 120 125

Claims (9)

1. a kind of 3 type of carp herpesviral, 1301 plants of ORF136 DNA recombinant expression albumen, it is characterised in that its full length amino acid sequence Row such as SEQ ID NO:Shown in 2.
2. a kind of nucleotides for encoding the recombinant expression protein described in claim 1, it is characterised in that its full length nucleotide base Sequence such as SEQ ID NO:Shown in 1.
3. a kind of polyclonal antibody, it is characterised in that with amino acid sequence such as SEQ ID NO:Recombinant expression protein shown in 5 is Obtained by antigen is prepared in immune animal.
4. the Antibody preparation described in claim 3 is used for the application for detecting the immune instrument of the type of lithium herpesviral 3.
5. the antibody described in claim 3 is in relevant disease caused by detection, prevention or the type infection for the treatment of carp herpesviral 3 Using.
6. a kind of method of the polyclonal antibody prepared described in claim 3, it is characterised in that specific preparation process is as follows:
1) expand:Using 3 type of carp herpesviral, 1301 plants of DNA as template, design specific primer is to ORF136 gene coded proteins Performing PCR amplification is entered in 31st~157 amino acids region, obtains recombinant cloning vector pMD18-T-ORF136;
2) build:Recombinant cloning vector pMD18-T-ORF136, prokaryotic expression carrier pET-32a (+) are subjected to double digestion respectively After connect, build recombinant prokaryotic expression vector pET-32a-ORF136;
3) express:PET-32a-ORF136 is converted to Escherichia coli Rosetta and obtained after IPTG induced expressions such as SEQ ID NO:Recombinant expression protein shown in 5;
4) prepare:Will be such as SEQ ID NO:Recombinant expression protein shown in 5 is taken a blood sample after being immunized in immune animal;To blood Polyclonal antibody is obtained after being handled.
7. method according to claim 6, it is characterised in that
The step 2) in the system of digestion be:10 × buffer 2ul, EcoR I and Xho I each 1ul, plasmid 1ug, mend ddH2O Water is to 20ul;37 DEG C of water-bath digestion 2h;
The step 2) in connection system be:T4Ligase 1.5uL, 10 × T4Ligase buffer 1.5uL, pET-32a (+) 3uL, the fragment 9uL after digestion;16 DEG C of connections are stayed overnight.
8. method according to claim 6, it is characterised in that the step 3) in pET32a-ORF136 convert to large intestine In bacillus Rosetta, screening positive clone is inoculated in the LB culture mediums containing ammonia benzyl, and culture to OD600 is 0.4, is added IPTG is carried out after induced expression, and thalline is collected by centrifugation, and thalline is cleaned, crushed, collected after centrifugation inclusion body protein, is forgiven Body protein obtains recombinant expression protein after purification.
9. method according to claim 6, it is characterised in that the step 4) in recombinant expression protein in immune animal Carry out subcutaneous multi-point injection to be immunized, taken a blood sample after being immunized;After blood is stood, centrifugation collects serum, with the side of affinity purification Formula antagonistic Serum is purified, and obtains polyclonal antibody.
CN201710076686.6A 2017-02-13 2017-02-13 3 type of carp herpesviral, 1301 plants of ORF136 DNA recombinant expressions albumen, antibody and its application Pending CN107056898A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201710076686.6A CN107056898A (en) 2017-02-13 2017-02-13 3 type of carp herpesviral, 1301 plants of ORF136 DNA recombinant expressions albumen, antibody and its application

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201710076686.6A CN107056898A (en) 2017-02-13 2017-02-13 3 type of carp herpesviral, 1301 plants of ORF136 DNA recombinant expressions albumen, antibody and its application

Publications (1)

Publication Number Publication Date
CN107056898A true CN107056898A (en) 2017-08-18

Family

ID=59598160

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201710076686.6A Pending CN107056898A (en) 2017-02-13 2017-02-13 3 type of carp herpesviral, 1301 plants of ORF136 DNA recombinant expressions albumen, antibody and its application

Country Status (1)

Country Link
CN (1) CN107056898A (en)

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107827980A (en) * 2017-10-11 2018-03-23 中国水产科学研究院珠江水产研究所 Carp herpesviral truncates ORF132 DNA recombinant expressions albumen, antibody and its application
CN108017694A (en) * 2018-01-26 2018-05-11 广东省农业科学院动物卫生研究所 PORF65 recombinant proteins and its preparation method and application
CN108047317A (en) * 2018-02-08 2018-05-18 广东省农业科学院动物卫生研究所 PORF148 recombinant proteins and its preparation method and application
CN108178787A (en) * 2017-12-28 2018-06-19 广东省农业科学院动物卫生研究所 PORF131 recombinant proteins and its preparation method and application
CN110407920A (en) * 2019-07-29 2019-11-05 盐城工学院 A kind of prokaryotic expression, the method for purifying proteins of carp herpesvirusⅡtype capsid protein ORF66
CN114685619A (en) * 2021-06-23 2022-07-01 中国检验检疫科学研究院 Antigen protein, monoclonal antibody or polyclonal antibody thereof and application

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20080274126A1 (en) * 2005-01-26 2008-11-06 Dionisius Elisabeth Antonius Florack Oral Vaccines for Fish
CN104450627A (en) * 2014-12-24 2015-03-25 广东省农业科学院动物卫生研究所 Monoclonal antibody of cyprinid herpesvirus III envelope protein ORF132, hybridoma cell strain and application of monoclonal antibody

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20080274126A1 (en) * 2005-01-26 2008-11-06 Dionisius Elisabeth Antonius Florack Oral Vaccines for Fish
CN104450627A (en) * 2014-12-24 2015-03-25 广东省农业科学院动物卫生研究所 Monoclonal antibody of cyprinid herpesvirus III envelope protein ORF132, hybridoma cell strain and application of monoclonal antibody

Non-Patent Citations (15)

* Cited by examiner, † Cited by third party
Title
ACCESSION NO.JQ247180: "Cyprinid herpesvirus 3 isolate KHV-GZ10 ORF136 gene, complete cds", 《GENBANK》 *
CHUANFU DONG等: "Emergence of fatal European genotype CyHV-3/KHV in mainland China", 《VETERINARY MICROBIOLOGY》 *
DANIELA ROSENKRANZ等: "Identification of envelope protein pORF81 of koi herpesvirus", 《JOURNAL OF GENERAL VIROLOGY》 *
WALTER FUCHS等: "Identification of structural proteins of koi herpesvirus", 《ARCHIVES OF VIROLOGY》 *
刘厚奇等: "《原位检测技术》", 31 March 2012, 第二军医大学出版社 *
刘春杰等: "锦鲤疱疹病毒_CJ株ORF136基因的克隆及生物信息学分析", 《兽医科学》 *
吕世静: "《临床免疫学检验》", 31 August 2004, 中国医药科技出版社 *
吕文亮: "锦鲤疱疹病毒ORF126、OFR136基因克隆、表达及免疫评价", 《中国优秀硕士学位论文全文数据库农业科技辑》 *
孙志贤: "《现代生物化学理论与研究技术》", 30 April 1995, 军事医学科学出版社 *
廖红等: "鲤疱疹病毒2型ORF5截短基因的克隆表达及免疫原性研究", 《中国兽医科学》 *
戈贤平: "《专家与成功养殖者共谈 现代高效大宗淡水鱼养殖实战方》", 31 December 2015, 金盾出版社 *
柯浩等: "锦鲤疱疹病毒囊膜蛋白ORF59的克隆、分析及其主要B细胞表位区的原核表达", 《南方水产》 *
王友超等: "锦鲤疱疹病毒CJ株ORF27基因克隆及生物信息学分析", 《水产学杂志》 *
王好等: "锦鲤疱疹病毒-CJ株ORF136基因的原核表达及免疫原性研究", 《中国兽药杂志》 *
黄健等: "《简明生物信息学》", 30 November 2014, 电子科技大学出版社 *

Cited By (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107827980A (en) * 2017-10-11 2018-03-23 中国水产科学研究院珠江水产研究所 Carp herpesviral truncates ORF132 DNA recombinant expressions albumen, antibody and its application
CN108178787A (en) * 2017-12-28 2018-06-19 广东省农业科学院动物卫生研究所 PORF131 recombinant proteins and its preparation method and application
CN108178787B (en) * 2017-12-28 2019-10-18 广东省农业科学院动物卫生研究所 PORF131 recombinant protein and its preparation method and application
CN108017694A (en) * 2018-01-26 2018-05-11 广东省农业科学院动物卫生研究所 PORF65 recombinant proteins and its preparation method and application
CN108017694B (en) * 2018-01-26 2019-10-18 广东省农业科学院动物卫生研究所 PORF65 recombinant protein and its preparation method and application
CN108047317A (en) * 2018-02-08 2018-05-18 广东省农业科学院动物卫生研究所 PORF148 recombinant proteins and its preparation method and application
CN110407920A (en) * 2019-07-29 2019-11-05 盐城工学院 A kind of prokaryotic expression, the method for purifying proteins of carp herpesvirusⅡtype capsid protein ORF66
CN114685619A (en) * 2021-06-23 2022-07-01 中国检验检疫科学研究院 Antigen protein, monoclonal antibody or polyclonal antibody thereof and application
CN114685619B (en) * 2021-06-23 2024-02-13 中国检验检疫科学研究院 Antigen protein, monoclonal antibody or polyclonal antibody and application thereof

Similar Documents

Publication Publication Date Title
CN107056898A (en) 3 type of carp herpesviral, 1301 plants of ORF136 DNA recombinant expressions albumen, antibody and its application
Tian et al. Development of a novel candidate subunit vaccine against Grass carp reovirus Guangdong strain (GCRV-GD108)
CN103539842B (en) Recombinant protein coded by grass carp reovirus (GCRV) type-II S10 gene, polyclonal antibody prepared from recombinant protein and application of recombinant protein
CN113956362B (en) Recombinant feline parvovirus VP2 protein antigen and application thereof in antibody diagnosis and vaccine preparation
AU2020102599A4 (en) Indirect ELISA Detection Method and Application of DHAV-3 Antibody Based on VP2 or VP4 Recombinant Protein Antigen
Venkatesan et al. Expression and evaluation of recombinant P32 protein based ELISA for sero-diagnostic potential of capripox in sheep and goats
CN112877348B (en) African swine fever virus CD2v extracellular domain recombinant protein and application thereof
CN106442981B (en) A kind of 1 type antibody indirect ELISA diagnostic kit of human bocavirus
CN105462937B (en) A kind of enterovirus vaccine for chimeric virus-like particles and its preparation method and application
CN106866796A (en) The recombinant protein of the type S9 gene codes of GCRV II and its application
CN109402069A (en) A kind of pseudovirion and its preparation method and application
CN113604438B (en) Monoclonal antibody for resisting tilapia lake virus, cell strain and application thereof
CN109212230B (en) Sensitized polystyrene nano-microsphere for detecting canine parvovirus structural protein VP2 antibody and preparation method and application thereof
CN105273065A (en) 1-type duck hepatitis A virus VP2 recombinant protein, ELISA kit and preparation method thereof
CN107167609B (en) Distinguish the antibody indirect ELISA detection method of pig blue-ear disease street strain and the strain of vaccine strain Tianjin
CN102690327A (en) Enterovirus 71 neutralized epitope polypeptide and application thereof
CN113637056A (en) Kit for identifying Brucella melitensis and Brucella melitensis of other species
CN112125961B (en) Bovine viral diarrhea-bovine infectious rhinotracheitis bigeminal subunit fusion vaccine and identification method thereof
CN109402065A (en) One kind kind duck C hypotype fowl metapneumovirus low virulent strain and its preparation and application
CN109239341A (en) A kind of indirect ELISA reagent kit of ox Mannheimia haemolytica antibody test and its application
CN105646680B (en) The application of brucella S2 vaccine GL_0002181 albumen
CN105693831B (en) A kind of detection reagent and its application of brucella S2 vaccine immunity antibody
CN111621506A (en) Mycoplasma bovis secretory protein Mbovp0145 and application thereof
CN113512098B (en) Indirect ELISA (enzyme-Linked immuno sorbent assay) method for identifying swine fever virus and bovine viral diarrhea virus serum antibodies and application thereof
Shooshtari et al. Capripoxvirus identification by PCR based on P32 gene

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
RJ01 Rejection of invention patent application after publication

Application publication date: 20170818

RJ01 Rejection of invention patent application after publication